ArticleJournal of natural medicines2026
Comparative pharmaco dynamic material basis and COX-2/PGE2-mediated anti-RA mechanism of wild and simulated-wild cultivated Saposhnikovia divaricata.
Article in Journal of natural medicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Saposhnikoviae Radix (SR) is a traditional Chinese herbal medicine widely used for the treatment of "Bi syndrome". The cultivation patterns of SR have been adjusted in response to wild resource scarcity. Different cultivation patterns directly affect the appearance, chemical constituents and pharmacological efficacy of SR. However, the mechanism of SR from various patterns against rheumatoid arthritis (RA) remains unclear. This study systematically studied morphological characteristics, chemical constituents, and therapeutic efficacy against RA between wild-sourced SR (WS-SR) and simulated-wild cultivated SR (SWC-SR). Putative bioactive constituents and their underlying target pathways were prioritized through integrated LC-MS analysis and network pharmacology. The therapeutic efficacy was validated using an adjuvant-induced arthritis (AIA) rat model, while the molecular mechanisms of putative active constituents were elucidated in MH7A cells, focusing on the modulation of the COX-2/PGE2 signaling pathway. Our findings demonstrated that both WS-SR and SWC-SR exerted significant anti-RA efficacy. Notably, 5-O-methylvisammioside was identified as a potential bioactive constituent which significantly inhibited inflammatory responses via the COX-2/PGE2 signaling pathway. By elucidating the critical pathways and main targets of SR, this study provided new insights evidence to support the feasibility of simulated-wild cultivation as a viable and effective alternative to wild populations for sustainable medicinal production.
Indexed as
Identifiers
42380414What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.